Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.3%
    Check dated 2025-06-19T19:36:52.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:11:22.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.4%
    Check dated 2025-05-29T05:55:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the efficacy, safety, and tolerability of dolutegravir-rilpivirine for HIV-1 maintenance therapy, which is a significant loss of core content.
    Difference
    0.1%
    Check dated 2025-05-07T19:21:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:56:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the addition of new collaborators, a revision number update, and the removal of detailed study information regarding the efficacy and safety of a specific HIV treatment regimen.
    Difference
    20%
    Check dated 2025-04-16T02:14:06.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.